Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer in Vitro and Inflammatory Bowel Disease in Vivo

PLoS ONE - United States
doi 10.1371/journal.pone.0175659
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases

Advances in Protein Chemistry and Structural Biology
BiochemistryStructural Biology
2017English

Novel Therapeutic Targets in Inflammatory Bowel Disease

Prescriber
Pharmacology
2019English

Cancer and Reconstructive Surgery in Inflammatory Bowel Disease

Linköping University Medical Dissertations
2019English

Immunotherapy in Inflammatory Bowel Disease: Novel and Emerging Treatments

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Differential Activation of NF-κB and Nitric Oxide in Lymphocytes Regulates in Vitro and in Vivo Radiosensitivity

Mutation Research - Genetic Toxicology and Environmental Mutagenesis
MutagenesisToxicologyHealthGenetics
2010English

Variable NF-κB Pathway Responses in Colon Cancer Cells Treated With Chemotherapeutic Drugs

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Induction of cIAP-2 in Human Colon Cancer Cells Through PKCδ/NF-κB

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment in Vitro and in Vivo via ATM/NF-κB/IKK Pathway-Induced Apoptosis

PLoS ONE
Multidisciplinary
2013English

Correction: Antibiotics and Probiotics in Inflammatory Bowel Disease: When to Use Them?

Frontline Gastroenterology
HepatologyGastroenterology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy